Phoniatric studies in myasthenia gravis patients [Phoniatrische untersuchungen an patienten mit myasthenia gravis]

被引:0
作者
Tóth L.
Pap U.
Diószeghy P.
Sziklai I.
机构
[1] HNO-Klinik (Direktor: Prof. Dr. I. Sziklai),
[2] Universität Debrecen,undefined
[3] Ungarn,undefined
[4] Neurologie-Klinik (Direktor: Prof. Dr. L. Csiba),undefined
[5] Universität Debrecen,undefined
[6] Ungarn,undefined
关键词
Myasthenia gravis; Phoniatrics; Voice profile;
D O I
10.1007/s001060050479
中图分类号
学科分类号
摘要
The authors have for the first time evaluated the basic parameters of the voice using computed voice analysis in patients with myasthenia gravis (MG). The aim of the study was to introduce an objective method suitable for the assessment of dysphonic symptoms, which predominate in bulbar, oculobulbar and generalized MG. Voice profile studies included the evaluation of the singing voice range, voice dynamics, maximum phonation time, and mean fundamental frequency and intensity, during speech. The characteristic of the stroboscopic picture was also determine. Investigations were carried out before and after the intake of Mestinon, a reversible cholinesterase inhibitor, and healthy subjects were used as a control group. In MG, the voice range and dynamics are badly impaired, maximum phonation time is shortened, the mean fundamental frequency during speech is increased, while the intensity is decreased. Mestinon resulted in an improvement in all these parameters, however, they were still impaired in comparison to the control subjects. Most changes were found to be statistically significant. The authors emphasize the role of the otolaryngologist and objective phoniatric methods in the evaluation of MG and other myasthenia-like neurological diseases. The use of these methods for the assessment of phoniatric symptoms in neurological diseases is highly recommended.
引用
收藏
页码:981 / 985
页数:4
相关论文
共 50 条
  • [21] Treatment of Myasthenia Gravis
    Vikas Kumar
    Henry J. Kaminski
    Current Neurology and Neuroscience Reports, 2011, 11 : 89 - 96
  • [22] Myasthenia gravis and Pregnancy
    Klehmet, J.
    Ohlraun, S.
    Meisel, A.
    AKTUELLE NEUROLOGIE, 2014, 41 (08) : 447 - 453
  • [23] Distal myasthenia gravis
    Renard, Dimitri
    Castelnovo, Giovanni
    Labauge, Pierre
    ACTA NEUROLOGICA BELGICA, 2008, 108 (03) : 107 - 108
  • [24] Myasthenia gravis and pregnancy
    Roche, P.
    Bouhour, F.
    REVUE NEUROLOGIQUE, 2021, 177 (03) : 215 - 219
  • [25] Cholesterol in myasthenia gravis
    Paz, Mariela L.
    Barrantes, Francisco J.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2021, 701
  • [26] Treatment of Myasthenia Gravis
    Kumar, Vikas
    Kaminski, Henry J.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2011, 11 (01) : 89 - 96
  • [27] Juvenile myasthenia gravis
    Papazian, Oscar
    Alfonso, Israel
    Araguez, Nayle
    MEDICINA-BUENOS AIRES, 2009, 69 (01) : 71 - 83
  • [28] Myasthenia gravis in childhood
    Anlar, B
    Ozdirim, E
    Renda, Y
    Yalaz, K
    Aysun, S
    Topcu, M
    Topaloglu, H
    ACTA PAEDIATRICA, 1996, 85 (07) : 838 - 842
  • [29] Complement and myasthenia gravis
    Sanderson, Nicholas S. R.
    MOLECULAR IMMUNOLOGY, 2022, 151 : 11 - 18
  • [30] COGNITIVE FATIGUE IN PATIENTS WITH MYASTHENIA GRAVIS
    Jordan, Berit
    Schweden, Tabea L. K.
    Mehl, Theresa
    Menge, Uwe
    Zierz, Stephan
    MUSCLE & NERVE, 2017, 56 (03) : 449 - 457